Investing.com | May 20, 2020 07:03
US futures for the S&P 500, Dow Jones and NASDAQ pushed higher on Wednesday, after Tuesday's sharp selloff during the final hour of Wall Street trading. European stocks opened lower this morning while Asian indices finished mostly higher earlier today.
Yields are rebounding, the dollar is flat and oil is hovering around the $32 mark.
Contracts on US indices are suggesting that investors are prepared to drive stocks back up when the New York session opens, even though yesterday’s late decline was spurred by doubts about Moderna's (NASDAQ:MRNA) potential COVID-19 vaccine.
SPX futures are testing the top of range in place since late April. From above, the 100 and 200 moving averages weigh on the contract. A downside breakout of the range’s lows, would complete a small double top, while an upside breakout would merely be the onset of another rally.
Earlier this morning European stocks were still playing catch-up to yesterday’s Wall Street selloffs, before they turned higher. They could be coming back on either a short squeeze triggered by spurned vaccine hopes or by dip-buying of the ever hopeful. In the first hours of trade, the STOXX Europe 600 Index fell with banks and industrial goods stocks.
Asian trading was mixed as investors waded through conflicting themes: concerns over a persistent pandemic—with 4,913,761 confirmed coronavirus cases globally and 323,637 deaths—after market enthusiasm over Moderna’s vaccine breakthrough turned out to be premature; and chances of an economic recovery amid a reopening global economy.
Bargain hunters targeted India’s BSE Sensex, pushing it to outperformance, (+2.06%). It's seen to still be catching up to the region’s recovery from the March lows. It currently provides just 19 times earnings, making it more than a third cheaper than its December peak when the metric was 30 times earnings.
Yesterday, the Dow, S&P 500, NASDAQ and Russell 2000 all took a dive when medical professionals clarified that Moderna did not produce sufficient data to establish definitively that they’re on the path to a bonafide vaccine for COVID-19. The biotech's stock valuation soared to $29 billion, despite having no product to sell, a reminder of the Dotcom era, when internet companies with no free cash flow, revenues or assets were priced at multiples of 40.
The selloff on the S&P 500 confirmed the resistance since late April. Considering the location below the 100 and 200 MAs, we might be witnessing the setup for a double top, to confirm a rising wedge, with the 50 DMA acting as a neckline.
Yields, including for the 10-year Treasury, are rebounding.
The yield on the benchmark note is rebounding, retesting the neckline of a small double top, within the 4-hour chart’s timeframe, which confirmed a two-week resistance at 0.74. Lower interest in Treasurys and perhaps in US stocks after yesterday’s selloff, let the dollar edge lower, extending a decline to the third day, within a symmetrical triangle since March 27.
Gold climbed for the second day.
Oil slipped below $32, though at the time of writing the commodity has scrambled back above that level.
Any move below $32 would threaten to upend a four-day rally of over 30%. Technically, we see another correction, followed by another high, with which to call an uptrend, if we ignoring the subzero pricing blip.
Written By: Investing.com
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
More markets insights, more alerts, more ways to customize assets watchlists only on the App
More content, faster quotes and charts, and a smoother experience is available only on the App.